Bromfenac, Dimetapp Allergy, Nasahist B, Dimetane
Therapeutic: allergy, cold, and cough remedies, antihistamines
Symptomatic relief of allergic symptoms (rhinitis, urticaria) caused by histamine release. Severe allergic or hypersensitivity reactions, including anaphylaxis and transfusion reactions.
Antagonizes the effects of histamine at H1-receptor sites; does not bind to or inactivate histamine. Therapeutic Effects: Decreased symptoms of histamine excess (sneezing, rhinorrhea, nasal and ocular pruritus, ocular tearing and redness).
Adverse Reactions/Side Effects
CNS: drowsiness, sedation, dizziness, excitation (in children). EENT: blurred vision. CV: hypertension, arrhythmias, hypotension, palpitations. GI: dry mouth, constipation, obstruction. GU: retention, urinary hesitancy. Derm: sweating. Misc: hypersensitivity reaction (IV use).
PHYSICAL THERAPY IMPLICATIONS
Examination and Evaluation
Assess blood pressure (BP) and compare to normal values (See Appendix F). Report changes in BP, either a problematic decrease in BP (hypotension) or a sustained increase in BP (hypertension).
Assess heart rate, ECG, and heart sounds, especially during exercise (See Appendices G, H). Report any rhythm disturbances or symptoms of increased arrhythmias, including palpitations, chest discomfort, shortness of breath, fainting, and fatigue/weakness.
Monitor signs of hypersensitivity reactions during and after IV administration. Signs include pulmonary symptoms (tightness in the throat and chest, wheezing, cough, dyspnea) or skin reactions (rash, pruritus, urticaria). Notify physician or nursing staff immediately if these reactions occur.
Monitor symptoms of nasal allergies (sneezing, rhinitis, itching eyes, cough) or chronic urticaria (rash, hives, itching) to help document benefits of this drug in treating these disorders.
When treating anaphylaxis: assess for signs of successful treatment, including decreased skin reactions (rash, urticaria) and increased airway patency and ventilation (decreased dyspnea, wheezing, and so forth).
Assess dizziness and drowsiness that might affect gait, balance, and other functional activities (See Appendix C). Report balance problems and functional limitations to the physician, and caution the patient and family/caregivers to guard against falls and trauma.
Monitor signs of increased excitation in children. Severe or problematic excitation may require a change in dose or drug.
Guard against falls and trauma (hip fractures, head injury, and so forth). Implement fall-prevention strategies, especially in older adults or if balance is impaired (See Appendix E).
Because of an increased risk of arrhythmias and abnormal BP responses, use caution during aerobic exercise and other forms of therapeutic exercise Assess exercise tolerance frequently (BP, heart rate, fatigue levels), and terminate exercise immediately if any untoward responses occur (See Appendix L).
Log In to View More
If your institution is currently a subscriber
of the F.A. Davis PT Collection please sign in below.
If your institution is not a subscriber
please click here
to learn more.
Want remote access to your institution's subscription?
Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.
If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
Pop-up div Successfully Displayed
This div only appears when the trigger link is hovered over.
Otherwise it is hidden from view.